Photodynamic therapy with Verteporfin in subfoveal choroidal metastasis of breast carcinoma (a controlled case)

Neuro Endocrinol Lett. 2006 Dec;27(6):725-8.

Abstract

A 55-year old woman with growing unilateral subfoveal choroidal metastasis of breast carcinoma was treated by photodynamic therapy (PDT) with verteporfin. Best corrected visual acuity remained stable during the whole follow-up of 6 months. Tumor flattened from 2.2 mm to 0 mm on ultrasound one month after the therapy. PDT with verteporfin appears to be the best tolerated method for palliative treatment of growing subfoveal choroidal metastasis of the breast carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Carcinoma, Medullary / drug therapy*
  • Carcinoma, Medullary / secondary
  • Choroid Neoplasms / drug therapy*
  • Choroid Neoplasms / secondary
  • Female
  • Humans
  • Middle Aged
  • Palliative Care / methods*
  • Photochemotherapy / methods*
  • Photosensitizing Agents / therapeutic use*
  • Porphyrins / therapeutic use*
  • Treatment Outcome
  • Verteporfin
  • Visual Acuity

Substances

  • Antineoplastic Agents
  • Photosensitizing Agents
  • Porphyrins
  • Verteporfin